REV3L single nucleotide variants lead to increased susceptibility towards non-small cell lung cancer in the population of Jammu and Kashmir

Non-small cell lung cancer (NSCLC) is the most common lung cancer, accounting for 80–85% of all lung cancer cases. Various genetic studies have associated REV3L (Protein reversion less 3-like) gene mutations, which encodes the catalytic subunit of error prone translesion synthesis polymerase zeta wi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer epidemiology 2021-12, Vol.75, p.102047-102047, Article 102047
Hauptverfasser: Jamwal, Rajeshwer Singh, Mahajan, Nikita, Bhat, Gh. Rasool, Bhat, Amrita, Shah, Ruchi, Verma, Sonali, Sharma, Minerva, Sharma, Bhawani, Qadri, Raies A., Kumar, Rakesh, Bhat, Audesh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 102047
container_issue
container_start_page 102047
container_title Cancer epidemiology
container_volume 75
creator Jamwal, Rajeshwer Singh
Mahajan, Nikita
Bhat, Gh. Rasool
Bhat, Amrita
Shah, Ruchi
Verma, Sonali
Sharma, Minerva
Sharma, Bhawani
Qadri, Raies A.
Kumar, Rakesh
Bhat, Audesh
description Non-small cell lung cancer (NSCLC) is the most common lung cancer, accounting for 80–85% of all lung cancer cases. Various genetic studies have associated REV3L (Protein reversion less 3-like) gene mutations, which encodes the catalytic subunit of error prone translesion synthesis polymerase zeta with cancer, including lung cancer; however, no such data is available from any North Indian population. In this study we attempted to screen the North Indian population of Jammu and Kashmir (J&K) for the potential role of REV3L gene polymorphisms in NSCLC. A total of four REV3L single nucleotide variants were selected for genotyping based on the available literature. The genotyping was carried out by using the TaqMan allele discrimination assay in 500 subjects (200 NSCLC patients and 300 age and sex matched healthy controls). The association of variants with NSCLC was evaluated by logistic regression. Out of the four REV3L variants genotyped; rs1002481, rs462779, and rs465646 were found significantly associated with NSCLC risk under the recessive model, with an Odds Ratio (OR) of 3.52(2.14–5.8 at 95% CI, p-value = 0.00000062), 3.7 (1.8–7.6 at 95% CI, p-value = 0.00031), and 2.2 (1.47–3.37 at 95% CI, p-value = 0.0003), respectively. Our data supports a strong association between variants rs1002481, rs462779, rs465646 and NSCLC, indicating a potential role of these REV3L variants in increasing the risk for the development of NSCLC in the studied population. Although a first report from any Indian population, these variants have been previously reported to be associated with lung and colorectal cancers in different world populations. Our data along with the existing data supports the notation that these variants can be used as potential genetic predisposition markers. Data generated and analysed during study is not available publicly but can be made available from the corresponding author upon reasonable request. •Translesion DNA polymerases are emerging as an important player in oncogenesis.•Recent studies have highlighted the role of these genes as a cause for increased susceptibility towards different cancers.•Our study is a first report from any North Indian population showing the role of TLS gene polymorphisms in cancer.•Of the four SNVs genotype, we found three SNVs significantly associated with NSCLC.•The association of these SNVs was significantly correlated with the habit of smoking.
doi_str_mv 10.1016/j.canep.2021.102047
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2582806949</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1877782121001648</els_id><sourcerecordid>2582806949</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-5c6b0b6d53711d1bfce34b5599d915d4e6fd3e05ddfa2e535bdac7d3901d28a3</originalsourceid><addsrcrecordid>eNp9kctu1DAUhiMEoqXwBEjIEhs2GXyJnWTBAlXlOlKlqkLsLMc-aT1y7OBLUZ-hL42HKV10wca27O-c8_v_m-Y1wRuCiXi_22jlYd1QTEm9objrnzTHZOj7th_Yz6cPZ0qOmhcp7TAWghD-vDlineB8pOy4ubs4-8G2KFl_5QD5oh2EbA2gGxWt8jkhB8qgHJD1OoJKYFAqScOa7WSdzbf17beKJiEffJsW5RzSUBdX_BWqCjXEWovyNaA1rMWpbINHYUbf1LIUpLxB31W6Xmx82TyblUvw6n4_aS4_nV2efmm355-_nn7ctpoNfW65FhOehOGsJ8SQadbAuqn-ZzQj4aYDMRsGmBszKwqc8cko3Rs2YmLooNhJ8-7Qdo3hV4GU5WLTXnJ1M5QkKR_ogMXYjRV9-wjdhRJ9FSepwJj2gglWKXagdAwpRZjlGu2i4q0kWO6jkjv5Nyq5j0oeoqpVb-57l2kB81DzL5sKfDgAUL24sRBl0haqn8ZG0FmaYP874A8gUae6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2600276363</pqid></control><display><type>article</type><title>REV3L single nucleotide variants lead to increased susceptibility towards non-small cell lung cancer in the population of Jammu and Kashmir</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Jamwal, Rajeshwer Singh ; Mahajan, Nikita ; Bhat, Gh. Rasool ; Bhat, Amrita ; Shah, Ruchi ; Verma, Sonali ; Sharma, Minerva ; Sharma, Bhawani ; Qadri, Raies A. ; Kumar, Rakesh ; Bhat, Audesh</creator><creatorcontrib>Jamwal, Rajeshwer Singh ; Mahajan, Nikita ; Bhat, Gh. Rasool ; Bhat, Amrita ; Shah, Ruchi ; Verma, Sonali ; Sharma, Minerva ; Sharma, Bhawani ; Qadri, Raies A. ; Kumar, Rakesh ; Bhat, Audesh</creatorcontrib><description>Non-small cell lung cancer (NSCLC) is the most common lung cancer, accounting for 80–85% of all lung cancer cases. Various genetic studies have associated REV3L (Protein reversion less 3-like) gene mutations, which encodes the catalytic subunit of error prone translesion synthesis polymerase zeta with cancer, including lung cancer; however, no such data is available from any North Indian population. In this study we attempted to screen the North Indian population of Jammu and Kashmir (J&amp;K) for the potential role of REV3L gene polymorphisms in NSCLC. A total of four REV3L single nucleotide variants were selected for genotyping based on the available literature. The genotyping was carried out by using the TaqMan allele discrimination assay in 500 subjects (200 NSCLC patients and 300 age and sex matched healthy controls). The association of variants with NSCLC was evaluated by logistic regression. Out of the four REV3L variants genotyped; rs1002481, rs462779, and rs465646 were found significantly associated with NSCLC risk under the recessive model, with an Odds Ratio (OR) of 3.52(2.14–5.8 at 95% CI, p-value = 0.00000062), 3.7 (1.8–7.6 at 95% CI, p-value = 0.00031), and 2.2 (1.47–3.37 at 95% CI, p-value = 0.0003), respectively. Our data supports a strong association between variants rs1002481, rs462779, rs465646 and NSCLC, indicating a potential role of these REV3L variants in increasing the risk for the development of NSCLC in the studied population. Although a first report from any Indian population, these variants have been previously reported to be associated with lung and colorectal cancers in different world populations. Our data along with the existing data supports the notation that these variants can be used as potential genetic predisposition markers. Data generated and analysed during study is not available publicly but can be made available from the corresponding author upon reasonable request. •Translesion DNA polymerases are emerging as an important player in oncogenesis.•Recent studies have highlighted the role of these genes as a cause for increased susceptibility towards different cancers.•Our study is a first report from any North Indian population showing the role of TLS gene polymorphisms in cancer.•Of the four SNVs genotype, we found three SNVs significantly associated with NSCLC.•The association of these SNVs was significantly correlated with the habit of smoking.</description><identifier>ISSN: 1877-7821</identifier><identifier>EISSN: 1877-783X</identifier><identifier>DOI: 10.1016/j.canep.2021.102047</identifier><identifier>PMID: 34655923</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Body mass index ; Cancer ; Carcinoma, Non-Small-Cell Lung - epidemiology ; Carcinoma, Non-Small-Cell Lung - genetics ; Case-Control Studies ; Cell cycle ; Chemical synthesis ; DNA damage ; DNA polymerase zeta ; DNA repair gene ; DNA-Binding Proteins - genetics ; DNA-Directed DNA Polymerase - genetics ; Epidemiology ; Gene polymorphism ; Genes ; Genetic Predisposition to Disease ; Genomes ; Genotyping ; Haplotypes ; Humans ; Lung cancer ; Lung Neoplasms - epidemiology ; Lung Neoplasms - genetics ; Males ; Materials information ; Mutation ; Non-small cell lung cancer (NSCLC) ; Non-small cell lung carcinoma ; Nucleotides ; Polymorphism, Single Nucleotide ; Population ; Population studies ; Regression analysis ; REV3L (Protein reversion less 3-like) ; Reversion ; Small cell lung carcinoma ; Squamous cell carcinoma ; World population</subject><ispartof>Cancer epidemiology, 2021-12, Vol.75, p.102047-102047, Article 102047</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><rights>2021. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-5c6b0b6d53711d1bfce34b5599d915d4e6fd3e05ddfa2e535bdac7d3901d28a3</citedby><cites>FETCH-LOGICAL-c387t-5c6b0b6d53711d1bfce34b5599d915d4e6fd3e05ddfa2e535bdac7d3901d28a3</cites><orcidid>0000-0002-2892-3910</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2600276363?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34655923$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jamwal, Rajeshwer Singh</creatorcontrib><creatorcontrib>Mahajan, Nikita</creatorcontrib><creatorcontrib>Bhat, Gh. Rasool</creatorcontrib><creatorcontrib>Bhat, Amrita</creatorcontrib><creatorcontrib>Shah, Ruchi</creatorcontrib><creatorcontrib>Verma, Sonali</creatorcontrib><creatorcontrib>Sharma, Minerva</creatorcontrib><creatorcontrib>Sharma, Bhawani</creatorcontrib><creatorcontrib>Qadri, Raies A.</creatorcontrib><creatorcontrib>Kumar, Rakesh</creatorcontrib><creatorcontrib>Bhat, Audesh</creatorcontrib><title>REV3L single nucleotide variants lead to increased susceptibility towards non-small cell lung cancer in the population of Jammu and Kashmir</title><title>Cancer epidemiology</title><addtitle>Cancer Epidemiol</addtitle><description>Non-small cell lung cancer (NSCLC) is the most common lung cancer, accounting for 80–85% of all lung cancer cases. Various genetic studies have associated REV3L (Protein reversion less 3-like) gene mutations, which encodes the catalytic subunit of error prone translesion synthesis polymerase zeta with cancer, including lung cancer; however, no such data is available from any North Indian population. In this study we attempted to screen the North Indian population of Jammu and Kashmir (J&amp;K) for the potential role of REV3L gene polymorphisms in NSCLC. A total of four REV3L single nucleotide variants were selected for genotyping based on the available literature. The genotyping was carried out by using the TaqMan allele discrimination assay in 500 subjects (200 NSCLC patients and 300 age and sex matched healthy controls). The association of variants with NSCLC was evaluated by logistic regression. Out of the four REV3L variants genotyped; rs1002481, rs462779, and rs465646 were found significantly associated with NSCLC risk under the recessive model, with an Odds Ratio (OR) of 3.52(2.14–5.8 at 95% CI, p-value = 0.00000062), 3.7 (1.8–7.6 at 95% CI, p-value = 0.00031), and 2.2 (1.47–3.37 at 95% CI, p-value = 0.0003), respectively. Our data supports a strong association between variants rs1002481, rs462779, rs465646 and NSCLC, indicating a potential role of these REV3L variants in increasing the risk for the development of NSCLC in the studied population. Although a first report from any Indian population, these variants have been previously reported to be associated with lung and colorectal cancers in different world populations. Our data along with the existing data supports the notation that these variants can be used as potential genetic predisposition markers. Data generated and analysed during study is not available publicly but can be made available from the corresponding author upon reasonable request. •Translesion DNA polymerases are emerging as an important player in oncogenesis.•Recent studies have highlighted the role of these genes as a cause for increased susceptibility towards different cancers.•Our study is a first report from any North Indian population showing the role of TLS gene polymorphisms in cancer.•Of the four SNVs genotype, we found three SNVs significantly associated with NSCLC.•The association of these SNVs was significantly correlated with the habit of smoking.</description><subject>Body mass index</subject><subject>Cancer</subject><subject>Carcinoma, Non-Small-Cell Lung - epidemiology</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Case-Control Studies</subject><subject>Cell cycle</subject><subject>Chemical synthesis</subject><subject>DNA damage</subject><subject>DNA polymerase zeta</subject><subject>DNA repair gene</subject><subject>DNA-Binding Proteins - genetics</subject><subject>DNA-Directed DNA Polymerase - genetics</subject><subject>Epidemiology</subject><subject>Gene polymorphism</subject><subject>Genes</subject><subject>Genetic Predisposition to Disease</subject><subject>Genomes</subject><subject>Genotyping</subject><subject>Haplotypes</subject><subject>Humans</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - epidemiology</subject><subject>Lung Neoplasms - genetics</subject><subject>Males</subject><subject>Materials information</subject><subject>Mutation</subject><subject>Non-small cell lung cancer (NSCLC)</subject><subject>Non-small cell lung carcinoma</subject><subject>Nucleotides</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Population</subject><subject>Population studies</subject><subject>Regression analysis</subject><subject>REV3L (Protein reversion less 3-like)</subject><subject>Reversion</subject><subject>Small cell lung carcinoma</subject><subject>Squamous cell carcinoma</subject><subject>World population</subject><issn>1877-7821</issn><issn>1877-783X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kctu1DAUhiMEoqXwBEjIEhs2GXyJnWTBAlXlOlKlqkLsLMc-aT1y7OBLUZ-hL42HKV10wca27O-c8_v_m-Y1wRuCiXi_22jlYd1QTEm9objrnzTHZOj7th_Yz6cPZ0qOmhcp7TAWghD-vDlineB8pOy4ubs4-8G2KFl_5QD5oh2EbA2gGxWt8jkhB8qgHJD1OoJKYFAqScOa7WSdzbf17beKJiEffJsW5RzSUBdX_BWqCjXEWovyNaA1rMWpbINHYUbf1LIUpLxB31W6Xmx82TyblUvw6n4_aS4_nV2efmm355-_nn7ctpoNfW65FhOehOGsJ8SQadbAuqn-ZzQj4aYDMRsGmBszKwqc8cko3Rs2YmLooNhJ8-7Qdo3hV4GU5WLTXnJ1M5QkKR_ogMXYjRV9-wjdhRJ9FSepwJj2gglWKXagdAwpRZjlGu2i4q0kWO6jkjv5Nyq5j0oeoqpVb-57l2kB81DzL5sKfDgAUL24sRBl0haqn8ZG0FmaYP874A8gUae6</recordid><startdate>202112</startdate><enddate>202112</enddate><creator>Jamwal, Rajeshwer Singh</creator><creator>Mahajan, Nikita</creator><creator>Bhat, Gh. Rasool</creator><creator>Bhat, Amrita</creator><creator>Shah, Ruchi</creator><creator>Verma, Sonali</creator><creator>Sharma, Minerva</creator><creator>Sharma, Bhawani</creator><creator>Qadri, Raies A.</creator><creator>Kumar, Rakesh</creator><creator>Bhat, Audesh</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2892-3910</orcidid></search><sort><creationdate>202112</creationdate><title>REV3L single nucleotide variants lead to increased susceptibility towards non-small cell lung cancer in the population of Jammu and Kashmir</title><author>Jamwal, Rajeshwer Singh ; Mahajan, Nikita ; Bhat, Gh. Rasool ; Bhat, Amrita ; Shah, Ruchi ; Verma, Sonali ; Sharma, Minerva ; Sharma, Bhawani ; Qadri, Raies A. ; Kumar, Rakesh ; Bhat, Audesh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-5c6b0b6d53711d1bfce34b5599d915d4e6fd3e05ddfa2e535bdac7d3901d28a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Body mass index</topic><topic>Cancer</topic><topic>Carcinoma, Non-Small-Cell Lung - epidemiology</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Case-Control Studies</topic><topic>Cell cycle</topic><topic>Chemical synthesis</topic><topic>DNA damage</topic><topic>DNA polymerase zeta</topic><topic>DNA repair gene</topic><topic>DNA-Binding Proteins - genetics</topic><topic>DNA-Directed DNA Polymerase - genetics</topic><topic>Epidemiology</topic><topic>Gene polymorphism</topic><topic>Genes</topic><topic>Genetic Predisposition to Disease</topic><topic>Genomes</topic><topic>Genotyping</topic><topic>Haplotypes</topic><topic>Humans</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - epidemiology</topic><topic>Lung Neoplasms - genetics</topic><topic>Males</topic><topic>Materials information</topic><topic>Mutation</topic><topic>Non-small cell lung cancer (NSCLC)</topic><topic>Non-small cell lung carcinoma</topic><topic>Nucleotides</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Population</topic><topic>Population studies</topic><topic>Regression analysis</topic><topic>REV3L (Protein reversion less 3-like)</topic><topic>Reversion</topic><topic>Small cell lung carcinoma</topic><topic>Squamous cell carcinoma</topic><topic>World population</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jamwal, Rajeshwer Singh</creatorcontrib><creatorcontrib>Mahajan, Nikita</creatorcontrib><creatorcontrib>Bhat, Gh. Rasool</creatorcontrib><creatorcontrib>Bhat, Amrita</creatorcontrib><creatorcontrib>Shah, Ruchi</creatorcontrib><creatorcontrib>Verma, Sonali</creatorcontrib><creatorcontrib>Sharma, Minerva</creatorcontrib><creatorcontrib>Sharma, Bhawani</creatorcontrib><creatorcontrib>Qadri, Raies A.</creatorcontrib><creatorcontrib>Kumar, Rakesh</creatorcontrib><creatorcontrib>Bhat, Audesh</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jamwal, Rajeshwer Singh</au><au>Mahajan, Nikita</au><au>Bhat, Gh. Rasool</au><au>Bhat, Amrita</au><au>Shah, Ruchi</au><au>Verma, Sonali</au><au>Sharma, Minerva</au><au>Sharma, Bhawani</au><au>Qadri, Raies A.</au><au>Kumar, Rakesh</au><au>Bhat, Audesh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>REV3L single nucleotide variants lead to increased susceptibility towards non-small cell lung cancer in the population of Jammu and Kashmir</atitle><jtitle>Cancer epidemiology</jtitle><addtitle>Cancer Epidemiol</addtitle><date>2021-12</date><risdate>2021</risdate><volume>75</volume><spage>102047</spage><epage>102047</epage><pages>102047-102047</pages><artnum>102047</artnum><issn>1877-7821</issn><eissn>1877-783X</eissn><abstract>Non-small cell lung cancer (NSCLC) is the most common lung cancer, accounting for 80–85% of all lung cancer cases. Various genetic studies have associated REV3L (Protein reversion less 3-like) gene mutations, which encodes the catalytic subunit of error prone translesion synthesis polymerase zeta with cancer, including lung cancer; however, no such data is available from any North Indian population. In this study we attempted to screen the North Indian population of Jammu and Kashmir (J&amp;K) for the potential role of REV3L gene polymorphisms in NSCLC. A total of four REV3L single nucleotide variants were selected for genotyping based on the available literature. The genotyping was carried out by using the TaqMan allele discrimination assay in 500 subjects (200 NSCLC patients and 300 age and sex matched healthy controls). The association of variants with NSCLC was evaluated by logistic regression. Out of the four REV3L variants genotyped; rs1002481, rs462779, and rs465646 were found significantly associated with NSCLC risk under the recessive model, with an Odds Ratio (OR) of 3.52(2.14–5.8 at 95% CI, p-value = 0.00000062), 3.7 (1.8–7.6 at 95% CI, p-value = 0.00031), and 2.2 (1.47–3.37 at 95% CI, p-value = 0.0003), respectively. Our data supports a strong association between variants rs1002481, rs462779, rs465646 and NSCLC, indicating a potential role of these REV3L variants in increasing the risk for the development of NSCLC in the studied population. Although a first report from any Indian population, these variants have been previously reported to be associated with lung and colorectal cancers in different world populations. Our data along with the existing data supports the notation that these variants can be used as potential genetic predisposition markers. Data generated and analysed during study is not available publicly but can be made available from the corresponding author upon reasonable request. •Translesion DNA polymerases are emerging as an important player in oncogenesis.•Recent studies have highlighted the role of these genes as a cause for increased susceptibility towards different cancers.•Our study is a first report from any North Indian population showing the role of TLS gene polymorphisms in cancer.•Of the four SNVs genotype, we found three SNVs significantly associated with NSCLC.•The association of these SNVs was significantly correlated with the habit of smoking.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>34655923</pmid><doi>10.1016/j.canep.2021.102047</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-2892-3910</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1877-7821
ispartof Cancer epidemiology, 2021-12, Vol.75, p.102047-102047, Article 102047
issn 1877-7821
1877-783X
language eng
recordid cdi_proquest_miscellaneous_2582806949
source MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland
subjects Body mass index
Cancer
Carcinoma, Non-Small-Cell Lung - epidemiology
Carcinoma, Non-Small-Cell Lung - genetics
Case-Control Studies
Cell cycle
Chemical synthesis
DNA damage
DNA polymerase zeta
DNA repair gene
DNA-Binding Proteins - genetics
DNA-Directed DNA Polymerase - genetics
Epidemiology
Gene polymorphism
Genes
Genetic Predisposition to Disease
Genomes
Genotyping
Haplotypes
Humans
Lung cancer
Lung Neoplasms - epidemiology
Lung Neoplasms - genetics
Males
Materials information
Mutation
Non-small cell lung cancer (NSCLC)
Non-small cell lung carcinoma
Nucleotides
Polymorphism, Single Nucleotide
Population
Population studies
Regression analysis
REV3L (Protein reversion less 3-like)
Reversion
Small cell lung carcinoma
Squamous cell carcinoma
World population
title REV3L single nucleotide variants lead to increased susceptibility towards non-small cell lung cancer in the population of Jammu and Kashmir
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T21%3A05%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=REV3L%20single%20nucleotide%20variants%20lead%20to%20increased%20susceptibility%20towards%20non-small%20cell%20lung%20cancer%20in%20the%20population%20of%20Jammu%20and%20Kashmir&rft.jtitle=Cancer%20epidemiology&rft.au=Jamwal,%20Rajeshwer%20Singh&rft.date=2021-12&rft.volume=75&rft.spage=102047&rft.epage=102047&rft.pages=102047-102047&rft.artnum=102047&rft.issn=1877-7821&rft.eissn=1877-783X&rft_id=info:doi/10.1016/j.canep.2021.102047&rft_dat=%3Cproquest_cross%3E2582806949%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2600276363&rft_id=info:pmid/34655923&rft_els_id=S1877782121001648&rfr_iscdi=true